Read the Latest
Children's Hospital is part of the UPMC family.
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #9 Nationally by U.S. News & World Report.
The Division of Medical Genetics at UPMC Children’s Hospital of Pittsburgh maintains an active basic science and clinical research program. Our research is providing new insight into genetic disorders from which new and better therapies can be developed. The laboratory research program focuses on discovering the underlying causes of genetic diseases, understanding the clinical implications of mutations in genes, and development of novel approaches for treatment of genetic disorders. An active clinical research program collaborates with other genetic programs world wide to evaluate new therapies for genetic disease.
Research Contact Registry for Members of the Amish and Mennonite Communities
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults with Arginase 1 Deficiency
Laboratory Study of Acyl-CoA Dehydrogenases
Trial of Gene Therapy 4D-310 in Adult Males with Classic Fabry Disease
Study of the Efficacy and Safety of Ex Vivo, Lentiviral Vector-mediated Gene Therapy AVR-RD-01 for Treatment-Naïve Subjects with Classic Fabry Disease
Study of the Safety and Efficacy of PRX-102 compared to Agalsidase Beta on Renal Function in Patients with Fabry Disease Previously Treated With Agalsidase Beta
Study of Elelyso™ (Taliglucerase Alfa) in Pediatric Subjects with Type 1 Gaucher Disease
Active Surveillance Taliglucerase Alfa Registry in Patients with Gaucher Disease
An Observational, International, Multi-center, Long-Term Registry of Patients with Gaucher Disease
Use of Whole Exome and Genome Sequencing to Identify New Genetic Disorders
Use of Whole Exome Sequencing/Whole Genome Sequencing in the Plain Communities
Whole Genome Sequencing in the Intensive Care Unit Population
Hereditary Hemorrhagic Telangiectasia and Vascular Malformations Registry and Sample Repository
Long-term Registry of Patients with Hypophosphatasia
Inborn Errors of Metabolism Information System (IBEM-IS)
Investigation of the Common MELAS Mutation in the Northwestern Pennsylvania Amish Community: Mutation Frequency and Effectiveness of an Educational Intervention
Natural History Study of Children with Metachromatic Leukodystrophy
Study of hLB-001 Gene Therapy in Pediatric Patients with Methylmalonic Acidemia Characterized by MMUT Mutations
MaP: Mapping the Patient Journey in Methylmalonic and Propionic Acidemia, A Longitudinal, Exploratory, Natural History Study to Further Characterize and Describe the Signs and Symptoms of Patients with Organic Acidemias
A Global, Multi-Center, Long-Term, Observational Registry of Patients with Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II)
Extension of Study HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Intrathecal Idursulfase-IT Administered in Conjunction with Intravenous Elaprase® in Pediatric Patients with Hunter Syndrome and Cognitive Impairment
Extension of Study HGT-HIT-094 Evaluating Long-Term Safety and Clinical Outcomes of Intrathecal Idursulfase Administered in Conjunction with Elaprase® in Patients with Hunter Syndrome and Cognitive Impairment
Morquio A Registry Study (MARS)
Mucopolysaccharidosis Type VI Clinical Surveillance Program
Longitudinal Investigation of Neurodegenerative Disorders in Children
Study in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated With BPS804
Clinical and Basic Investigations into Phosphomannomutase Deficiency
A Prospective Clinical Study of Phenylketonuria
PKUDOS - PKU Demographics, Outcomes, and Safety Registry
Whole Body Turnover Studies of 1-13C Phe in Patients with Phenylketonuria
Dose Escalation Study to Evaluate the Safety and Efficacy of HMI-102 in Adult PKU Subjects with PAH Deficiency
Hepatocyte Transplantation for Phenylketonuria
Study of the Efficacy and Safety of SYNB1618 in Subjects with Phenylketonuria
Chart Review of Patients Who Have the Amish/Mennonite Variant of Propionic Acidemia
A Stool and Biological Specimen Sampling Study in Subjects with Propionic or Methylmalonic Acidemia
Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants with Propionic Acidemia
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency
Long-Term Registry of Patients With Urea Cycle Disorders
Study to Evaluate the Efficacy and Safety of KB195 in Subjects with a Urea Cycle Disorder with Inadequate Control on Standard of Care
Study of the Safety, Pharmacokinetics and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients with Urea Cycle Disorders
Eric Goetzman, PhD
Al-Walid A. Mohsen, PhD
Robert Nicholls, PhD
Yudong Wang, PhD
Jennifer Baker, MA
Danielle Black, BS
Sandra Braden, RN
Michele Graham, RN
Nadene Henderson, MS, LCGC
Angela Leshinski, RD, LDN
Jessica Lindenberger, RN
Elizabeth McCracken MS, LCGC
Tatiana Pomerantz, BS
Catherine Walsh Vockley MS, LCGC
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Support the hospital by making a donation online, joining our Heroes in Healing monthly donor program, or visiting our site to learn about the other ways you can give back.